Heart-Lung connection may explain survival advantage in Parasite-Linked hypertension

NCT ID NCT07707193

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study looks at how well the right side of the heart works with the lungs in people who have high blood pressure in their lung arteries caused by schistosomiasis, a parasitic infection common in parts of Africa and South America. Researchers will use echocardiography to measure a key ratio called TAPSE/PASP, which reflects how efficiently the heart pumps blood against the increased pressure. The goal is to understand why some patients with this condition tend to live longer than those with other forms of pulmonary hypertension.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help explain why some patients with schistosomiasis-related pulmonary hypertension live longer than those with other forms of the disease.
What could go wrong
This is an observational study with only 50 participants, so findings may not apply to all patients. It measures heart function but does not test any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHISTOSOMIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mansoura university hospitals

    Al Mansurah, Egypt

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.